Sr One Capital Management, LP Portfolio Holdings

Sr One Capital Management, LP

  • $295 Million
  • Q3 2024

Sr One Capital Management, LP has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $295 Million distributed in 11 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arcellx, Inc. with a value of $196M, Crispr Therapeutics Ag with a value of $49.3M, Design Therapeutics, Inc. with a value of $35.1M, Nkarta, Inc. with a value of $15.1M, and Alumis Inc. with a value of $0.

Examining the 13F form we can see an increase of $67.7M in the current position value, from $228M to 295M.

Below you can find more details about Sr One Capital Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $295 Million
Healthcare: $295 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$117M
$15.1 Million 5.1% of portfolio
3,333,333
Q1 2024 Added 150.0%

Summary

  • Portfolio
  • No. of Stocks 11
  • Current Value $295 Million
  • Prior Value $228 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 2 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Sr One Capital Management, LP Portfolio

Follow Sr One Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sr One Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sr One Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email